´ëÇѾȽŰæÀÇÇÐȸ
  • ȸ¿ø°¡ÀÔ
  • ·Î±×ÀÎ
  • ȨÀ¸·Î
  • ´ëÇѾȽŰæÀÇÇÐȸ
    • ÇÐȸ¼Ò°³
    • Á¶Á÷µµ
    • ÀÓ¿øÁø
    • ȸĢ
  • ÇмúÇà»ç¾È³»
    • ÀüüÀÏÁ¤
    • »çÀüµî·Ï
    • ÃÊ·ÏÁ¢¼ö
    • ÃÊ·ÏÁ¢¼öÈ®ÀÎ
    • °­¿¬ÀÚ °­ÀÇ·Ï Á¢¼ö
    • Çà»çÀå ¾È³»
  • Áõ·ÊÀÚ·á½Ç
    • Áõ·ÊÀÚ·á½Ç
  • °£Ç๰
    • Åõ°í±ÔÁ¤
    • ÇÐȸÁö°Ë»ö
  • ȸ¿ø°ø°£
    • °øÁö»çÇ×
    • ȸ¿ø°Ë»ö
    • °Ô½ÃÆÇ
    • ÇÐȸ¼Ò½Ä
    • À§¿øÈ¸°ø°£
 
 
 
¹øÈ£ Á¦   ¸ñ ±Û¾´ÀÌ ³¯Â¥ Á¶È¸
123 2018 ´ë¾È½ÅÇÐ Ãß°è, Retinopathies mimicking optic neuropathy¡¦ ´ëÇѾȽŰæÀÇÇÐȸ 11-01 3945
122 2018 ´ë¾È½ÅÇÐ Ãß°è, Afferent visual dysfunction in neuro-deg¡¦ ´ëÇѾȽŰæÀÇÇÐȸ 11-01 3983
121 2018 ´ë¾È½ÅÇÐ Ãß°è, New treatment of nonarteritic anterior i¡¦ ´ëÇѾȽŰæÀÇÇÐȸ 11-01 3853
120 2018 ´ë¾È½ÅÇÐ Ãß°è, ¡°Dorsal Stream¡± Syndromes - ÀÌÀͼº(¼ø¡¦ ´ëÇѾȽŰæÀÇÇÐȸ 11-01 4271
119 2018 ´ë¾È½ÅÇÐ Ãß°è, 'Ventral stream' syndromes - ¡¦ ´ëÇѾȽŰæÀÇÇÐȸ 11-01 4060
118 2018 ´ë¾È½ÅÇÐ Ãß°è, Visual field test - ±èÇö¾Æ(°è¸íÀÇ´ë) ´ëÇѾȽŰæÀÇÇÐȸ 11-01 3960
117 2018 ´ë¾È½ÅÇÐ Ãß°è, Vision Visual Acuity & Color Vision- Á¤¡¦ ´ëÇѾȽŰæÀÇÇÐȸ 11-01 4077
116 2018 ´ë¾È½ÅÇÐ Ãß°è, Anatomy of afferent visual system: to th¡¦ ´ëÇѾȽŰæÀÇÇÐȸ 11-01 2928
115 2018 ´ë¾È½ÅÇÐ Ãß°è, Anatomy of afferent visual system -From ¡¦ ´ëÇѾȽŰæÀÇÇÐȸ 11-01 2802
114 2018 ´ë¾È½ÅÇÐ Ãá°è, Ocular tilt reaction -¹ÚÁöÀ±(¿ï»êÀÇ´ë) ´ëÇѾȽŰæÀÇÇÐȸ 06-28 3229
113 2018 ´ë¾È½ÅÇÐ Ãá°è,Basal ganglia and cerebrum-±è¼ºÈñ(°æºÏÀÇ¡¦ ´ëÇѾȽŰæÀÇÇÐȸ 05-31 2982
112 2018 ´ë¾È½ÅÇÐ Ãá°è,Cerebellum-°­ºÀÈñ(´Ü±¹ÀÇ´ë) ´ëÇѾȽŰæÀÇÇÐȸ 05-31 3167
111 2018 ´ë¾È½ÅÇÐ Ãá°è,Brainstem-±èÇö¾Æ(°è¸íÀÇ´ë) ´ëÇѾȽŰæÀÇÇÐȸ 05-31 2909
110 2018 ´ë¾È½ÅÇÐ Ãá°è,Orbit and cavernous sinus-ÃÖ¼­¿µ(ºÎ»êÀǴ롦 ´ëÇѾȽŰæÀÇÇÐȸ 05-31 3104
109 2018 ´ë¾È½ÅÇÐ Ãá°è,Updated medications in Neuro-ophthalmolog¡¦ ´ëÇѾȽŰæÀÇÇÐȸ 05-31 3223
 1  2  3  4  5  6  7  8  9